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Results
PwMS - Responses received from 1005 individuals, 736 completed and 
used for analysis: France 16.3%; Spain 15.6%; USA 13.6%; Poland 11.8%; 
Greece 10.1%; Romania 8.2%; England 5.6%; Australia 4.1%; Croatia 
3.9%; Italy 3.1%; others less than 3% (Sweden, Portugal, Slovenia, 
Canada, Serbia, the Netherlands, Switzerland, Germany).
•Access to healthcare resources (for examples see figures 1 and 2) and 
utilities (see figure 3) for PwMS varied across healthcare systems and 
types of MS. They did not vary according to early disease modifying 
therapy (within 12 months of a single neurological attack with MRI 
enhancing lesions) or late (after 12 months; data not shown).
•The average utility value reported was 0.6 (60% of perfect health), with 
a loss of 25% compared with the general population. 
•Caregivers - Responses received from 450 individuals, 122 completed 
and used for analysis: Spain 23.8%; Romania 18%; USA 13.1%; Greece 
10.7%; Poland 7.4%; England 6.6%; Germany 5.7%; France 4.1%; Italy 
3.3%; others less than 3% (Croatia, Australia, Sweden, Serbia).
•Caregivers reported better utility compared with PwMS (78% vs. 60% of 
perfect health; see figure 4). Both PWMS and caregivers reported a mild 
level of disability (14.4, Barthel score) and discomfort (16.3, Zarit score) 
respectively. Their experience of MS care varied across country settings. 
Methods
Information from patients/caregivers were collected through an 
anonymous online survey. Participation was open to adult 
MS/caregivers. The study was available in fifteen countries in Europe and 
overseas. Individuals were enrolled through MS-societies and clinics. The 
survey captured data on direct and indirect costs, patients' and 
caregivers' HRQoL (EuroQol-5D), patients' disability (Barthel-Index), 
burden among caregivers (Zarit-Burden-Interview), participants' 
experience, as well as demographic variables, and disease information. 
The societal, HRQoL and economic impact of MS management were 
evaluated across countries.
Conclusions
MS results in a significant socioeconomic impact as experienced both by 
PwMS and their caregivers. Further data collection will strengthen 
available evidence across country settings and inform the development 
of future services.
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Background & Objectives
Multiple-sclerosis (MS) is the most common cause of disability among central-nervous-system (CNS) diseases. The available data provide 
limited information on the impact and burden of MS as experienced by people living with MS (PwMS)/caregivers. If decisions on MS 
management and treatment availability are to reflect patient needs, international evidence to capture the full picture of the multiple 
domains of MS burden is needed.
The objectives of this study were to assess and compare the costs, health-related-quality-of-life (HRQoL), and experience reported by 
people living with MS/caregivers across international settings. 
Do you want to take part?
The Research team is inviting all people with MS, caregivers and clinicians to contribute. The 
surveys for PwMS/caregivers are available in the languages below: Croatian, Dutch, English, Estonian, 
French, German, Greek, Italian, Polish, Portuguese, Russian, Slovenian, Spanish, Swedish. All surveys 
(PwMS, caregivers and clinicians) can be accessed from here: http://www.emsp.org/news-
messages/impress-study/
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